American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$559M |
| 2 |
Mastercard
MA
|
+$301M |
| 3 |
Estee Lauder
EL
|
+$262M |
| 4 |
IQVIA
IQV
|
+$191M |
| 5 |
Arista Networks
ANET
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$624M |
| 2 |
Visa
V
|
+$533M |
| 3 |
Apple
AAPL
|
+$413M |
| 4 |
NVIDIA
NVDA
|
+$327M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.32% |
| 2 | Financials | 13.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Healthcare | 10.02% |
| 5 | Industrials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLL
2751
DELISTED
Piedmont Lithium
PLL
| $109K | ﹤0.01% |
+12,525
| New | +$147K |
|
2752
Xerox
XRX
$412M
| $108K | ﹤0.01% |
12,771
-6,199
| -33% | -$57.2K |
|
|
SGMO
2753
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $107K | ﹤0.01% |
+105,337
| New | +$193K |
|
2754
Sera Prognostics
SERA
$79.1M
| $107K | ﹤0.01% |
13,183
-198
| -1% | -$1.46K |
|
2755
Alector
ALEC
$240M
| $107K | ﹤0.01% |
56,735
-7,103
| -11% | -$26.7K |
|
|
YRD
2756
Yiren Digital
YRD
$105M
| $107K | ﹤0.01% |
+22,334
| New | +$125K |
|
2757
Acrivon Therapeutics
ACRV
$73.6M
| $106K | ﹤0.01% |
17,588
+2,186
| +14% | +$15.9K |
|
2758
inTEST
INTT
$179M
| $105K | ﹤0.01% |
12,209
-1,372
| -10% | -$10.4K |
|
2759
Ultralife
ULBI
$120M
| $105K | ﹤0.01% |
14,057
-73
| -0.5% | -$600 |
|
|
SNCR
2760
DELISTED
Synchronoss Technologies
SNCR
| $103K | ﹤0.01% |
+10,690
| New | +$114K |
|
|
CTV
2761
DELISTED
Innovid Corp.
CTV
| $100K | ﹤0.01% |
32,395
-428
| -1% | -$1.01K |
|
2762
Zentalis Pharmaceuticals
ZNTL
$307M
| $97.2K | ﹤0.01% |
32,084
+2,609
| +9% | +$8.55K |
|
2763
Tilly's
TLYS
$121M
| $95.5K | ﹤0.01% |
22,470
-361
| -2% | -$1.47K |
|
2764
Douglas Elliman
DOUG
$184M
| $94.5K | ﹤0.01% |
56,605
+33,011
| +140% | +$63.5K |
|
2765
Acumen Pharmaceuticals
ABOS
$182M
| $93.4K | ﹤0.01% |
54,278
-265
| -0.5% | -$638 |
|
2766
908 Devices
MASS
$414M
| $91K | ﹤0.01% |
41,343
-92
| -0.2% | -$263 |
|
2767
Sagimet Biosciences
SGMT
$584M
| $90.5K | ﹤0.01% |
+20,103
| New | +$102K |
|
2768
Zegna
ZGN
$3.76B
| $89.5K | ﹤0.01% |
10,840
| – | – |
|
2769
VistaGen Therapeutics
VTGN
$11.6M
| $88.5K | ﹤0.01% |
30,002
-195
| -0.6% | -$549 |
|
2770
PepGen
PEPG
$201M
| $85.7K | ﹤0.01% |
22,605
-175
| -0.8% | -$1.09K |
|
|
KALV
2771
DELISTED
KalVista Pharmaceuticals
KALV
| $85.3K | ﹤0.01% |
10,072
-24,651
| -71% | -$255K |
|
2772
Gaotu Techedu
GOTU
$410M
| $85.2K | ﹤0.01% |
38,912
| – | – |
|
|
EPIX
2773
DELISTED
ESSA Pharma
EPIX
| $83K | ﹤0.01% |
46,373
-279
| -0.6% | -$889 |
|
2774
Inovio Pharmaceuticals
INO
$79.6M
| $80K | ﹤0.01% |
43,697
+2,873
| +7% | +$12.7K |
|
|
PGRE
2775
DELISTED
Paramount Group
PGRE
| $76.3K | ﹤0.01% |
15,443
-69,787
| -82% | -$345K |
|
Similar funds
American Century Companies's Q4 2024 Portfolio in Review
As of Q4 2024, American Century Companies held 2,985 positions worth $174B, up 1.1% from $172B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
American Century Companies's Q4 2024 filing shows 111 new, 1,804 increased, 830 reduced and 103 closed positions. Its largest new stake was Invesco Senior Loan ETF: 5,148,559 shares worth $108M. The largest sale was Advanced Micro Devices, an estimated $624M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- American Century Companies's largest Q4 2024 buy was Invesco Senior Loan ETF: 5,148,559 shares worth $108M.
- American Century Companies added most to Broadcom in Q4 2024, an estimated $559M increase.
- American Century Companies's biggest Q4 2024 reduction was Advanced Micro Devices, cutting an estimated $624M.
- American Century Companies fully exited Vista Outdoor Inc. in Q4 2024, selling an estimated $64.3M.
- American Century Companies's ten largest holdings make up 28% of its $174B portfolio in Q4 2024.
- American Century Companies opened 111 new positions and closed 103 in Q4 2024.
- American Century Companies's portfolio value rose 1.1% quarter-over-quarter to $174B.
Based on American Century Companies's 13F filing for Q4 2024, filed 11 Feb 2025.